Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 25 of 667 for:    Russian Federation | Chile

A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. (REVISIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03329092
Recruitment Status : Suspended (Recruitment has been suspended in study C3601002 due to a delay in investigational product availability)
First Posted : November 1, 2017
Last Update Posted : May 20, 2020
Sponsor:
Collaborators:
Innovative Medicines Initiative (IMI) COMBACTE-CARE (EU)
Biomedical Advanced Research and Development Authority
Information provided by (Responsible Party):
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : November 14, 2021
Estimated Study Completion Date : November 30, 2021